Regen BioPharma Inc (OTCPK:RGBP)
$ 1.05 -0.05 (-4.55%) Market Cap: 4.32 Mil Enterprise Value: 5.14 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 39/100

Regen BioPharma Inc To Present at the Emerging Growth Conference Transcript

Feb 08, 2023 / 07:20PM GMT
Release Date Price: $4.05 (-22.86%)
Ana Berry
Berry Media, Inc - Moderator

Welcome back, everyone. Next up, we have Regen BioPharma, Inc. It trades on the OTC pink sheets under the symbol RGBP and RGBPP. It's focused on the immunology and immunotherapy space. This company is focused on rapidly advancing novel technologies through preclinical and Phase 1 and 2 clinical trials. Currently, the company is focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders.

Please welcome President and CEO, David Koos; as well as Harry Lander, Senior Scientific Consultant. Welcome, gentlemen.

David Koos
Regen BioPharma, Inc. - Chairman and CEO

Well, thank you. Good morning, Ana. How are you doing this morning?

Ana Berry
Berry Media, Inc - Moderator

I'm great. We're happy to hear you guys, so whenever you're ready for questions, call me back. I'll be here.

David Koos
Regen BioPharma, Inc. - Chairman and CEO

Okay. So I'd like to start out first with going through the itinerary

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot